Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
Stason Pharmaceuticals, Inc.
Provisional
Irvine, CA · united states
1 recall flag(s)
FDA Flags (1)
Class III Recall
Mar 2024
Stason Pharmaceuticals, Inc.
Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-91
Classification: Class III